StockDuty Jun 24, 2026 09:55 AM ET
CatalystEarnings

$UHS — BUY 📊

UHS
$145.69
+0.85%
HCA
$391.68
+1.22%
THC
$189.00
+2.75%
$UHS — BUY 📊 Universal Health Services, Inc., through its subsidiaries, owns and operates acute care hospitals, and outpatient and behavioral health care facilities in the United States. 🎯 Q2 2026 | Rev $4B | EPS $5.62 vs $5.46 🟢 💡 Consensus expects margin erosion from persistent labor cost inflation and payer mix headwinds, but UHS is proving better cost control and strong behavioral health demand, leading to positive estimate revisions. 📉 Reward/risk: 2.2:1 🏢 Business Quality: 6/10 - Stable hospital operator with acute and behavioral diversification, but high leverage and regulatory sensitivity cap the rating. 📊 Valuation: cheap - Trailing annualized P/E ~6.5x vs. historical 10-year median ~10x. EV/EBITDA ~5.5x vs. peers (HCA ~7.5x). 🔮 Catalyst: Q2 2026 earnings release 💰 Entry: $145.85, stop $134, target $172 📊 Our read: BUY. Full analysis → https://stockduty.xyz/s/UHS0624 Also in play: $HCA $THC $CYH $UHS $EHC $MCK
Universal Health Services, Inc., through its subsidiaries, owns and operates acute care hospitals, and outpatient and behavioral health care facilities in the United States.
Sources
pipeline